tamsulosin has been researched along with Local Neoplasm Recurrence in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Branchi, A; Castellani, D; Claudini, R; Dellabella, M; Gasparri, L | 1 |
| Kujala, PM; Murtola, TJ; Tammela, TL | 1 |
1 trial(s) available for tamsulosin and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Oncological safety and quality of life in men undergoing simultaneous transurethral resection of bladder tumor and prostate: results from a randomized controlled trial.
Topics: Aged; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Safety; Tamsulosin; Transurethral Resection of Prostate; Treatment Outcome; Urinary Bladder Neoplasms; Urological Agents | 2018 |
1 other study(ies) available for tamsulosin and Local Neoplasm Recurrence
| Article | Year |
|---|---|
High-grade prostate cancer and biochemical recurrence after radical prostatectomy among men using 5α-reductase inhibitors and alpha-blockers.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Azasteroids; Cohort Studies; Disease-Free Survival; Dutasteride; Finasteride; Finland; Humans; Kallikreins; Male; Neoplasm Grading; Neoplasm Recurrence, Local; Proportional Hazards Models; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Quinazolines; Sulfonamides; Survival Rate; Tamsulosin | 2013 |